West Pharmaceutical Services, Inc. 8-K Report: Key Insights for February 2025

Based on the provided section of the financial report, here are the key insights and important information extracted:

1. Company Information:

• Name: West Pharmaceutical Services, Inc.
• Location: 530 Herman O. West Drive, Exton, PA 19341-1147
• Phone Number: 610-594-2900
• CIK (Central Index Key): 0000105770
• Tax Identification Number: 23-1210010

2. SEC Filing Details:

• Filing Type: 8-K (Current Report)
• Filing Date: February 13, 2025

3. Stock Information:

• Common Stock: Par value of $0.25 per share
• Ticker Symbol: WST
• Exchange: NYSE (New York Stock Exchange)

4. Period of Report:

• Report Date: The report covers the date of February 13, 2025.

5. XBRL Information:

• XBRL Version: XML version 1.0
• Schema Reference: The report references an XSD schema file named "wst-20250213.xsd".

Insights:

• The filing is a current report (8-K), which typically provides important updates that a public company must disclose to investors, such as significant events or changes in the company.
• The date of the report indicates that the information is timely and relevant for stakeholders who are monitoring the company's performance or any significant events that might affect the stock.
• The presence of the XBRL format suggests that the company is utilizing modern reporting standards, which enhance the accessibility and analysis of financial data.

This information is crucial for investors and analysts who are evaluating West Pharmaceutical Services, Inc. for investment opportunities or regulatory compliance.